- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge eFilm achieves record revenues
Financial results for the third quarter, ended Sept. 30, at Merge eFilm showed a 44% increase in revenue over the year earlier period: $7.6 million compared with $5.3 million. Revenues were $20.2 million for the nine months ended Sept. 30, also an
Financial results for the third quarter, ended Sept. 30, at Merge eFilm showed a 44% increase in revenue over the year earlier period: $7.6 million compared with $5.3 million. Revenues were $20.2 million for the nine months ended Sept. 30, also an increase of 44% over the previous nine-month period. Net income for the quarter rose 55% to $1.6 million. Net income for the nine months increased 85% to $4.3 million. Results include approximately two and a half months of revenues from RIS Logic. The RIS Logic acquisition completed in late July strengthened Merge eFilm's product portfolio to include a full RIS/PACS solution. It also enhanced target market positioning and accelerated the effectiveness of operations, according to Richard A. Linden, Merge eFilm president and CEO.
Comparing Digital Breast Tomosynthesis to Digital Mammography: What a Long-Term Study Reveals
September 17th 2024In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
Can Radiomics Enhance Differentiation of Intracranial Aneurysms on Computed Tomography Angiography?
September 17th 2024Radiomics models offered a pooled AUC of 86 percent for differentiating between ruptured and unruptured intracranial aneurysms, according to a recently published meta-analysis.
Emerging PSMA Radioligand Therapy Shows Benefits for Metastatic Castration-Resistant Prostate Cancer
September 16th 2024The PSMA-targeted modality 177Lu-PNT2002 improved radiographic progression-free survival by 29 percent in patients with mCRPC in comparison to ARPI therapy, according to new phase 3 trial data presented at the ESMO Congress in Spain.
The Nonexistence of Perfect Balance in Radiology
September 16th 2024In the elusive pursuit of reconciling case volume and having an appropriate number of radiologists, the proverbial windsurfer may fare better than stand-up paddleboarders and daredevil surfers at navigating the waves of the profession.
